Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in transfusion-dependent beta-thalassemia
NCT06146478Phase 3Completed
- Sponsor
- Blood Care Clinic
- Start
- Jan 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in beta thalassemia, sponsored by Blood Care Clinic. Started Jan 2022; status: completed.
02
Drugs
thalidomide
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on NCT06146478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06146478.